Cargando…
Vascular-targeted therapies for Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is the most common muscular dystrophy and an X-linked recessive, progressive muscle wasting disease caused by the absence of a functional dystrophin protein. Dystrophin has a structural role as a cytoskeletal stabilization protein and protects cells against contract...
Autores principales: | Ennen, James P, Verma, Mayank, Asakura, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651321/ https://www.ncbi.nlm.nih.gov/pubmed/23618411 http://dx.doi.org/10.1186/2044-5040-3-9 |
Ejemplares similares
-
Vascular therapy for Duchenne muscular dystrophy (DMD)
por: Thapa, Sangharsha, et al.
Publicado: (2023) -
Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy
por: Verma, Mayank, et al.
Publicado: (2019) -
Implications of notch signaling in duchenne muscular dystrophy
por: Den Hartog, Lily, et al.
Publicado: (2022) -
Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019) -
Gene Therapy for Duchenne Muscular Dystrophy
por: Elangkovan, Nertiyan, et al.
Publicado: (2021)